News | March 12, 2025
Poly Medicure receives MDR certification for 54 products
The MDR certification reafirms that these products meet the highest safety, quality, and regulatory standards
The MDR certification reafirms that these products meet the highest safety, quality, and regulatory standards
USFDA inspection at Alembic Pharma's Bioequivalence facility
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner
Revenue up 11% to Rs 5,768 crore as compared to Rs 5,197 crore
Branded formulation business continues to perform well across domestic and export markets
Profit after Taxes registered strong growth of 22% to Rs. 162 crores versus Rs. 134 crores in Q3 FY24
Mehta is an industry veteran with over 25 years of experience in the pharmaceutical industry
Revenue from Operations for Q3 FY25 was Rs. 454.33 crore,
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
Subscribe To Our Newsletter & Stay Updated
